Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection

Broad-based, host-targeted therapeutics have the potential to ameliorate viral infections without inducing antiviral resistance. We identified lanthionine synthetase C-like 2 (LANCL2) as a new therapeutic target for immunoinflammatory diseases. To examine the therapeutic efficacy of oral NSC61610 ad...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Immunol
Main Authors: Leber, Andrew, Bassaganya-Riera, Josep, Tubau-Juni, Nuria, Zoccoli-Rodriguez, Victoria, Lu, Pinyi, Godfrey, Victoria, Kale, Shiv, Hontecillas, Raquel
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2017
Assuntos:
Immunology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5318425/
https://ncbi.nlm.nih.gov/pubmed/28270815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.00178
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares